Showing results (1-10 of 96) with videos related to
Sort By:
Pageof 10
Stroke|January 8, 1999
Neuroprotection for acute stroke: making clinical trials workK W Muir, D G GrossetClinical Neuropharmacology|August 1, 1997
Effects of prolonged infusions of the NMDA antagonist aptiganel hydrochloride (CNS 1102) in normal volunteersK W Muir, D G Grosset, K R LeesStroke|July 1, 1994
Interconversion of stroke scales. Implications for therapeutic trialsK W Muir, D G Grosset, K R LeesAnnals of the New York Academy of Sciences|September 15, 1995
Clinical pharmacology of CNS 1102 in volunteersK W Muir, D G Grosset, K R LeesJournal of Cardiovascular Pharmacology|May 1, 1995
Systemic and cerebral hemodynamic responses to the noncompetitive N-methyl-D-aspartate (NMDA) antagonist CNS 1102D G Grosset, K W Muir, K R LeesBritish Journal of Clinical Pharmacology|July 1, 1994
Pharmacological effects of the non-competitive NMDA antagonist CNS 1102 in normal volunteersK W Muir, D G Grosset, E Gamzu, et al.QJM : Monthly Journal of the Association of Physicians|June 29, 2000
Randomized trial of graded compression stockings for prevention of deep-vein thrombosis after acute strokeK W Muir, A Watt, G Baxter, et al.Lancet (London, England)|October 8, 1994
Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarctionC J Weir, G D Murray, F G Adams, et al.British Journal of Clinical Pharmacology|December 1, 1992
Clinical, radiological, and functional evaluation following acute strokeD G GrossetBritish Journal of Clinical Pharmacology|May 1, 1992
What have drugs to offer the patient with acute stroke?D G GrossetPageof 10